Stoke Therapeutics had a revenue of 13.82M in the quarter ending Jun 30, 2025, with -91.29%. This bring the company's revenue in the last twelve months to 199.89M, Decreased 4.71%. In the fiscal year ending Dec 31, 2024, Stoke Therapeutics had annual revenue of 36.55M with 316.34% growth.